The ESC Heart Failure Journal shares additional results from FAST BioMedical’s EMPAKT CHF clinical study.   INDIANAPOLIS (Dec. 10, 2021) — FAST BioMedical (FAST), a privately held late clinical-stage medical technology company, today announces theEuropean Society of Cardiology (ESC) Heart Failure Journal has published additional results from its fourth human […]